Anna Sundlöv nominated to the board of directors in Spago Nanomedical
Anna Sundlöv, clinical oncologist specialized in radionuclide therapy of cancer, is nominated to the board of Spago Nanomedical.“Anna brings expertise that is highly relevant to the Tumorad project for development of a new radionuclide therapy for cancer. The project has gained from the progress in the SpagoPix project that is now being prepared for clinical development. The progress allows us to increase the pace of development towards the clinic also for Tumorad”, says Eva Redhe, Chair of Spago Nanomedical. Anna Sundlöv is senior consultant in medical oncology, specialized in